Patients with Alzheimer's disease and dementia deserve our love and respect, but nothing can replace the full-time care and attention that a professional caregiver can provide. We should plan our care with care.
While some of these relationships were strong when looking at everyone as a group, not everyone with sleep problems has abnormalities in their spinal fluid. There was no link between biological markers in spinal fluid and obstructive sleep apnea.
Data from continued drug trials by Eli Lilly released this week show it might be possible, if the drug is taken early, to slow Alzheimer’s in patients with a mild form of the disease. However, a different set of data, presented by Biogen, failed to show statistically significant benefits for patients on a closely regulated dose. The bottom line: A final assessment will take more time and tests, even though scientists think their line of attack on the disease is the correct one